We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
MasterCraft Boat Holdings
MCFT
$607M
| $476K | ﹤0.01% |
22,167
+219
| +1% | +$4.57K |
|
827
Origin Bancorp
OBK
$1.7B
| $474K | ﹤0.01% |
13,724
+375
| +3% | +$13.9K |
|
828
Biglari Holdings Class B
BH
$1.18B
| $470K | ﹤0.01% |
1,451
| – | – |
|
829
Corpay
CPAY
$25.1B
| $464K | ﹤0.01% |
1,611
-47
| -3% | -$15K |
|
830
Inhibrx
INBX
$1.17B
| $462K | ﹤0.01% |
+13,719
| New | +$338K |
|
831
Universal Technical Institute
UTI
$2.15B
| $461K | ﹤0.01% |
14,171
| – | – |
|
832
HBT Financial
HBT
$1.31B
| $452K | ﹤0.01% |
17,949
+612
| +4% | +$15.7K |
|
833
Driven Brands
DRVN
$2.47B
| $446K | ﹤0.01% |
27,708
-40,547
| -59% | -$706K |
|
834
Colony Bankcorp
CBAN
$470M
| $446K | ﹤0.01% |
+26,197
| New | +$447K |
|
835
FS Bancorp
FSBW
$324M
| $446K | ﹤0.01% |
11,161
-2,696
| -19% | -$111K |
|
|
JHG
836
DELISTED
Janus Henderson
JHG
| $435K | ﹤0.01% |
+9,782
| New | +$422K |
|
837
Skillsoft
SKIL
$63.8M
| $433K | ﹤0.01% |
33,254
-30,807
| -48% | -$452K |
|
838
Biote Corp
BTMD
$67.9M
| $428K | ﹤0.01% |
142,730
-79,826
| -36% | -$285K |
|
|
CALY
839
Callaway Golf Company
CALY
$3.28B
| $427K | ﹤0.01% |
+44,955
| New | +$418K |
|
840
UroGen Pharma
URGN
$1.99B
| $426K | ﹤0.01% |
+21,376
| New | +$384K |
|
841
Heartland Express
HTLD
$1.04B
| $425K | ﹤0.01% |
50,696
-454,345
| -90% | -$3.85M |
|
842
Northeast Community Bancorp
NECB
$380M
| $423K | ﹤0.01% |
20,582
+650
| +3% | +$14.3K |
|
|
NLOP
843
Net Lease Office Properties
NLOP
$179M
| $411K | ﹤0.01% |
+13,867
| New | +$435K |
|
844
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $410K | ﹤0.01% |
4,373
| – | – |
|
845
Amplitude
AMPL
$1.16B
| $409K | ﹤0.01% |
38,162
-12,877
| -25% | -$153K |
|
846
Nurix Therapeutics
NRIX
$2.51B
| $405K | ﹤0.01% |
+43,863
| New | +$456K |
|
847
Allstate
ALL
$70.1B
| $404K | ﹤0.01% |
1,881
-82
| -4% | -$16.5K |
|
848
Verizon
VZ
$201B
| $401K | ﹤0.01% |
9,135
-378,676
| -98% | -$16.4M |
|
849
Intrepid Potash
IPI
$474M
| $399K | ﹤0.01% |
+13,058
| New | +$411K |
|
850
Greenlight Captial
GLRE
$586M
| $399K | ﹤0.01% |
31,413
-7,175
| -19% | -$93.7K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.